Skip to main content
. 2022 Nov 30;22:454. doi: 10.1186/s12890-022-02249-8

Table 3.

Toxicities observed in our patients during 30 days after initiation of gefitinib treatment

Toxicities N = 18
Number (%)
Any  ≥ Grade 3
Diarrhea 9 (50) 1 (5.6)
Rash 5 (28) 0 (0)
Anorexia 4 (22) 0 (0)
Fatigue 4 (22) 0 (0)
Nausea 2 (11) 0 (0)
Dry skin 2 (11) 0 (0)
Mucositis 2 (11) 0 (0)
AST increase 1 (5.6) 1 (5.6)
ALT increase 1 (5.6) 1 (5.6)
Vomiting 1 (5.6) 0 (0)
Pharyngitis 1 (5.6) 0 (0)

AST Aspartate aminotransferase, ALT Alanine aminotransferase